Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Selective serotonin

Beginning in the 1960s, ben2odia2epiae anxiolytics and hypnotics rapidly became the standard prescription dmg treatment. In the 1980s, buspkone [36505-84-7] (3), which acts as a partial agonist at the serotonin [50-67-9] (5-hydroxytryptamine, 5-HT) type lA receptor, was approved as treatment for generali2ed anxiety. More recently, selective serotonin reuptake inhibitors (SSRIs) have been approved for therapy of panic disorder and obsessive—compulsive behavior. [Pg.218]

Treatment of Major Depression. Dmgs commonly used for the treatment of depressive disorders can be classified heuristicaHy iato two main categories first-generation antidepressants with the tricycHc antidepressants (TCAs) and the irreversible, nonselective monoamine—oxidase (MAO) inhibitors, and second-generation antidepressants with the atypical antidepressants, the reversible inhibitors of monoamine—oxidase A (RIMAs), and the selective serotonin reuptake inhibitors (SSRIs). Table 4 fists the available antidepressants. [Pg.229]

Selective Serotonin Reuptake Inhibitors. In 1987, the FDA approved fluoxetine [54910-89-3] (42) for use in the treatment of major... [Pg.468]

Two recently introduced antidepressants are notable m that they are selective serotonin uptake inhibitors Citalopram (19) is reported to be as effective as amitriptyline m the treatment of endogenous depression [75, 16] Fluoxetine (20) as the hydrochlonde is approved for major depressive disorders mcludmg those with concomitant anxiety Interestmgly, it also appears useful m the treatment of obesity [17]... [Pg.1121]

MDMA overdose as well as the concomitant consumption of selective serotonin reuptake inhibitors (SSRI) with other dmgs that exert serotoninergic effects (such as inhibitors of monoamine oxidase) can rapidly lead to the serotonin syndrome. Its symptoms, which are reversible upon cessation, of the drug include confusion, muscle rigidity in the lower limbs, and hyperthermia suggesting an acute reaction to serotonin overflow in the CNS. Blocking the function of SERT outside the brain causes side effects (e.g., nausea), which may be due to elevated 5HT however , impairment of transporter function is not equivalent to direct activation of 5HT recqrtors in causing adverse effects such as fibrosis and pulmonary hypertension. [Pg.841]

Selective serotonine reuptake inhibitor (SSRI) is an abbreviation for the class of antidepressants known as the Selective Serotonin Reuptake Inhibitors. Examples of SSRIs include fluoxetine, paroxetine, citalopram, and sertraline. These drugs selectively inhibit the serotonin transporter thus prolonging the synaptic lifespan of the neurotransmitter serotonin. [Pg.1113]

Indeed, 5-HT is also a substrate for the 5-HT transporter, itself an important player in the treatment of depression, and more recently for the whole range of anxiety disorders spectrum (GAD, OCD, social and other phobias, panic and post-traumatic stress disorders). It is the target for SSRIs (selective serotonin reuptake inhibitors) such as fluoxetine, paroxetine, fluvoxamine, and citalopram or the more recent dual reuptake inhibitors (for 5-HT and noradrenaline, also known as SNRIs) such as venlafaxine. Currently, there are efforts to develop triple uptake inhibitors (5-HT, NE, and DA). Further combinations are possible, e.g. SB-649915, a combined 5-HTia, 5-HT1b, 5-HT1d inhibitor/selective serotonin reuptake inhibitor (SSRI), is investigated for the treatment of major depressive disorder. [Pg.1124]

VMATs are not inhibited by drugs such as cocaine, tricyclic antidqnessants and selective serotonin reuptake inhibitors that affect plasma membrane monoamine transport. Amphetamines have relatively selective effects on monoaminergic cells due to selective uptake by plasma membrane monoamine transporters, but their effect appears to be mediated by their ability as weak bases to reduce ApH, the driving force for vesicular monoamine transport that leads to efflux of the vesicular contents into the cytoplasm. [Pg.1282]

Antidepressants Trazodone, mirtazapine, paroxetine, other selective serotonin reuptake inhibitors venlafaxine... [Pg.135]

Patients seen for flashbacks are treated with oral diazepam (15—30 mg/day for adults) if symptoms of anxiety are severe (Rumack 1987). Neuroleptics, especially haloperidol, have been implicated in a transient increase in visual flashbacks and are not recommended (Moskowitz 1971 Strassman 1984). Risperidone and selective serotonin reuptake inhibitors may also worsen symptoms of hallucinogen persisting perception disorder (Halpern and Pope 2003). The patient needs assurance of the self-limiting nature of the phenomenon and its decreasing frequency of reoccurrence with time. The patient should be reminded that any future use of hallucinogens or marijuana may precipitate similar symptoms (Strassman 1984). [Pg.223]

Briggs G, Freeman R, Yaffe S Drugs in Pregnancy and Lactation A Reference Guide to Maternal and Fetal Risk. Philadelphia, Lippincott, Williams Wilkins, 2002 Chengappa KN, Kambhampati R, Perkins K, et al Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on neatment with selective serotonin reuptake inhibitor antidepressants. J Clin Psychiatry 62 503—508, 2001... [Pg.334]

The enantiomerically pure 3-arylglutaric ester are precursors for the synthesis of (—)-paroxetine [10], a selective serotonin reuptake inhibitor used in the treatment of depression, obsessive compulsive disorder, and panic, and (i )-Baclofen [11], a GABAb receptor agonist, which is used cHnically in the treatment of spasticity (Chart 5.1). [Pg.98]

The main focus of pharmacoeconomic studies of antidepressants has inevitably fallen on comparisons between tricyclic antidepressants (TCAs) and the more expensive selective serotonin reuptake inhibitors (SSRIs). Few data are available for comparisons within the SSRIs or for newer antidepressants. [Pg.45]

Anderson IM, Tomenson BM (1994). The efficacy of selective serotonin reuptake inhibitors in depression a meta-analysis of studies against tricyclic antidepressants. / Psychopharmacol 8, 238 9. [Pg.52]

CCOHTA] Canadian Coordinating Office for Health Technology Assessment (1997). Selective Serotonin Re-uptake Inhibitors (SSRIs) for Major DepressionyVdJxll The Cost-... [Pg.52]

Donoghue JM (1998). Selective serotonin re-uptake inhibitor use in primary care a five year naturalistic study. Clin Drug Invest 16, 453-62. [Pg.53]

Selective serotonin reuptake inhibitor antidepressant selection and anxiolytic and sedative hypnotic prescribing a multivariate analysis./ Clin Outcomes Manage 4, 16—22. [Pg.53]

Selective serotonin reuptake inhibitors metaanalysis of efficacy and acceptability. Br Med J 306,683-7. [Pg.55]

Sechter D, Lane RM (1997). Continuation therapy with selective serotonin re-uptake inhibitors./... [Pg.68]

There is, however, a unique risk in the bipolar form that antidepressant treatment may trigger a switch into mania. This may occur either as the natural outcome of recovery from depression or as a pharmacological effect of the drug. Particular antidepressants (the selective serotonin reuptake inhibitors) seem less liable to induce the switch into mania than other antidepressants or electroconvulsive therapy. Treatment for mania consists initially of antipsychotic medication, for instance the widely used haloperidol, often combined with other less specific sedative medication such as the benzodiazepines (lorazepam intramuscularly or diazepam orally). The manic state will usually begin to subside within hours and this improvement develops further over the next 2 weeks. If the patient remains disturbed with manic symptoms, additional treatment with a mood stabilizer may help. [Pg.71]


See other pages where Selective serotonin is mentioned: [Pg.204]    [Pg.227]    [Pg.232]    [Pg.468]    [Pg.469]    [Pg.469]    [Pg.360]    [Pg.176]    [Pg.149]    [Pg.112]    [Pg.213]    [Pg.841]    [Pg.982]    [Pg.1045]    [Pg.1113]    [Pg.1155]    [Pg.1502]    [Pg.281]    [Pg.284]    [Pg.488]    [Pg.1060]    [Pg.92]    [Pg.119]    [Pg.199]    [Pg.322]    [Pg.64]    [Pg.94]   


SEARCH



A Selective serotonin re-uptake inhibitors (

Alkaloids selective serotonin

And selective serotonin receptor inhibitors

Antidepressants MAOIs) selective serotonin

Antidepressants Monoamine oxidase inhibitors Serotonin-selective

Antidepressants selective serotonin inhibitors

Antidepressants selective serotonin reuptake

Antidepressants selective serotonin reuptake inhibitors

Antipsychotic drugs selective serotonin reuptake inhibitors with

Anxiety selective serotonin reuptake inhibitors

Children selective serotonin reuptake

Depression selective serotonin reuptake inhibitors

Depressive disorders selective serotonin reuptake inhibitors

Hormonal) Selective serotonin re-uptake inhibitors (

Insomnia selective serotonin reuptake inhibitors

Look up the names of both individual drugs and their drug groups to access full information Selective serotonin re-uptake inhibitors (

Medications selective serotonin reuptake inhibitors

Mirtazapine selective serotonin reuptake inhibitors with

NSAIDs) Selective serotonin re-uptake inhibitors (

Nausea selective serotonin receptor inhibitors

Nefazodone selective serotonin reuptake inhibitors with

Obsessive-compulsive disorder selective serotonin reuptake inhibitors

Panic disorder selective serotonin reuptake inhibitors

Posttraumatic stress disorder selective serotonin reuptake inhibitors

Reboxetine selective serotonin reuptake inhibitors with

Reuptake Dual Selective Serotonin Norepinephrine

SSNRI (selective serotonin norepinephrine

SSNRI (selective serotonin norepinephrine Reuptake

SSRIs (selective serotonin

SSRIs (selective serotonin fluoxetine

SSRIs (selective serotonin reuptake

SSRIs (selective serotonin reuptake side effects

SSRls (selective serotonin reuptake

Schizophrenia Selective serotonin reuptake inhibitors

Selected serotonin reuptake inhibitors

Selective Serotonin action

Selective Serotonin compared

Selective Serotonin disorders

Selective Serotonin side effects

Selective Serotonin stress disorder

Selective Serotonin therapeutic effects

Selective Serotonin withdrawal effect

Selective Serotonin-Norepinephrine Reuptake Inhibitors

Selective Serotonine Reuptake Inhibitors

Selective serotonin and

Selective serotonin and norepinephrine

Selective serotonin and norepinephrine reuptake inhibitors

Selective serotonin inhibitors

Selective serotonin re-uptake

Selective serotonin re-uptake inhibitors

Selective serotonin re-uptake inhibitors SSRIs)

Selective serotonin receptor agonists

Selective serotonin receptor inhibitor (SSRI

Selective serotonin reuptake

Selective serotonin reuptake 5-Hydroxytryptamine

Selective serotonin reuptake Prozac

Selective serotonin reuptake activation effects

Selective serotonin reuptake adverse effects

Selective serotonin reuptake fluoxetine

Selective serotonin reuptake fluoxetine, paroxetine, sertraline)

Selective serotonin reuptake indications

Selective serotonin reuptake inhibitor behavioral

Selective serotonin reuptake inhibitor metabolic

Selective serotonin reuptake inhibitors

Selective serotonin reuptake inhibitors (SSRIs side effects

Selective serotonin reuptake inhibitors . See

Selective serotonin reuptake inhibitors Citalopram Fluoxetine

Selective serotonin reuptake inhibitors Fluvoxamine Paroxetine Sertraline

Selective serotonin reuptake inhibitors MAOIs

Selective serotonin reuptake inhibitors MDMA)

Selective serotonin reuptake inhibitors SSRIs)

Selective serotonin reuptake inhibitors about

Selective serotonin reuptake inhibitors action

Selective serotonin reuptake inhibitors administration

Selective serotonin reuptake inhibitors adverse effects

Selective serotonin reuptake inhibitors alprazolam

Selective serotonin reuptake inhibitors amphetamines

Selective serotonin reuptake inhibitors analysis

Selective serotonin reuptake inhibitors and

Selective serotonin reuptake inhibitors anxiety disorders

Selective serotonin reuptake inhibitors anxiety from

Selective serotonin reuptake inhibitors anxiety with

Selective serotonin reuptake inhibitors anxiolytics

Selective serotonin reuptake inhibitors benzodiazepines

Selective serotonin reuptake inhibitors buspirone

Selective serotonin reuptake inhibitors characteristics

Selective serotonin reuptake inhibitors chemical structures

Selective serotonin reuptake inhibitors children

Selective serotonin reuptake inhibitors citalopram

Selective serotonin reuptake inhibitors classification

Selective serotonin reuptake inhibitors clinical trials

Selective serotonin reuptake inhibitors clozapine

Selective serotonin reuptake inhibitors death

Selective serotonin reuptake inhibitors depression from

Selective serotonin reuptake inhibitors discontinuation

Selective serotonin reuptake inhibitors discontinuation syndrome

Selective serotonin reuptake inhibitors dosing

Selective serotonin reuptake inhibitors drug administration

Selective serotonin reuptake inhibitors drug interactions

Selective serotonin reuptake inhibitors drug overdose

Selective serotonin reuptake inhibitors drug withdrawal

Selective serotonin reuptake inhibitors drugs

Selective serotonin reuptake inhibitors during pregnancy

Selective serotonin reuptake inhibitors effects

Selective serotonin reuptake inhibitors efficacy

Selective serotonin reuptake inhibitors enantiomers

Selective serotonin reuptake inhibitors enhanced

Selective serotonin reuptake inhibitors escitalopram

Selective serotonin reuptake inhibitors extended-release

Selective serotonin reuptake inhibitors fluoxetine

Selective serotonin reuptake inhibitors fluvoxamine

Selective serotonin reuptake inhibitors gastrointestinal

Selective serotonin reuptake inhibitors general

Selective serotonin reuptake inhibitors haloperidol

Selective serotonin reuptake inhibitors hyponatremia with

Selective serotonin reuptake inhibitors immediate

Selective serotonin reuptake inhibitors in children

Selective serotonin reuptake inhibitors in children and adolescents

Selective serotonin reuptake inhibitors in obsessive-compulsive disorder

Selective serotonin reuptake inhibitors indications

Selective serotonin reuptake inhibitors interactions

Selective serotonin reuptake inhibitors labeling

Selective serotonin reuptake inhibitors lactation

Selective serotonin reuptake inhibitors limits

Selective serotonin reuptake inhibitors lithium

Selective serotonin reuptake inhibitors liver

Selective serotonin reuptake inhibitors long-term effects

Selective serotonin reuptake inhibitors mediation

Selective serotonin reuptake inhibitors metabolism

Selective serotonin reuptake inhibitors moclobemide

Selective serotonin reuptake inhibitors monoamine oxidase

Selective serotonin reuptake inhibitors mood disorders from

Selective serotonin reuptake inhibitors nefazodone

Selective serotonin reuptake inhibitors nervous system

Selective serotonin reuptake inhibitors olanzapine

Selective serotonin reuptake inhibitors overdose

Selective serotonin reuptake inhibitors overview

Selective serotonin reuptake inhibitors paroxetine

Selective serotonin reuptake inhibitors pharmacodynamic

Selective serotonin reuptake inhibitors pharmacokinetic

Selective serotonin reuptake inhibitors pharmacology

Selective serotonin reuptake inhibitors pindolol

Selective serotonin reuptake inhibitors risperidone

Selective serotonin reuptake inhibitors second-generation effects

Selective serotonin reuptake inhibitors selectivity differences

Selective serotonin reuptake inhibitors sertraline

Selective serotonin reuptake inhibitors structure

Selective serotonin reuptake inhibitors suicidality from

Selective serotonin reuptake inhibitors toxicity

Selective serotonin reuptake inhibitors tramadol

Selective serotonin reuptake inhibitors trazodone

Selective serotonin reuptake inhibitors tricyclic antidepressant interactions with

Selective serotonin reuptake inhibitors tricyclic antidepressants

Selective serotonin reuptake inhibitors triptans

Selective serotonin reuptake inhibitors venlafaxine

Selective serotonin reuptake inhibitors with stimulants

Selective serotonin reuptake inhibitors withdrawal

Selective serotonin reuptake inhibitors withdrawal from

Selective serotonin reuptake inhibitors, 128 sumatriptan

Selective serotonin reuptake interactions

Selective serotonin reuptake management

Selective serotonin reuptake pharmacological properties

Selective serotonin reuptake receptor

Selective serotonin reuptake risks

Selective serotonin reuptake side effects

Selective serotonin reuptake with antipsychotics

Selective serotonin reuptake with monoamine oxidase

Selective serotonin reuptake with tricyclic antidepressants

Selective serotonin reuptake withdrawal

Selective serotonin uptake inhibitor

Serotonin reuptake inhibitors, selective dosage

Serotonin reuptake inhibitors, selective interaction with other drugs

Serotonin reuptake inhibitors, selective pharmacokinetics

Serotonin reuptake inhibitors, selective side effects

Serotonin-selective reuptake additional indications

Social anxiety disorder selective serotonin reuptake inhibitors

Subject selective serotonin reuptake inhibitors

Suicide selective serotonin reuptake

Synaptosomal Serotonin Uptake and Its Selective Inhibitors (SSRI)

Trazodone selective serotonin reuptake inhibitors with

Tricyclic antidepressants selective serotonin reuptake inhibitor interactions

Vomiting selective serotonin receptor inhibitors

© 2024 chempedia.info